{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T11:40:39Z","timestamp":1736509239357,"version":"3.32.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.revmed.2024.08.002","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T11:37:37Z","timestamp":1725449857000},"page":"40-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SIBO, quand un mythe devient r\u00e9alit\u00e9"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4060-4365","authenticated-orcid":false,"given":"Thomas","family":"Escoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4997-1487","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9rique","family":"Retornaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Plauzolles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Halfon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.revmed.2024.08.002_bib0300","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri2710","article-title":"Immune adaptations that maintain homeostasis with the intestinal microbiota","volume":"10","author":"Hooper","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"7285","key":"10.1016\/j.revmed.2024.08.002_bib0305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"issue":"S1","key":"10.1016\/j.revmed.2024.08.002_bib0310","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41430-018-0306-8","article-title":"Importance of gut microbiota in obesity","volume":"72","author":"Cornejo-Pareja","year":"2019","journal-title":"Eur J Clin Nutr"},{"issue":"34","key":"10.1016\/j.revmed.2024.08.002_bib0315","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.revmed.2024.08.002_bib0320","doi-asserted-by":"crossref","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2\u00a0diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.revmed.2024.08.002_bib0325","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1097\/RHU.0000000000001748","article-title":"Dysbiosis and gut microbiota modulation in systemic sclerosis","volume":"28","author":"Lemos","year":"2022","journal-title":"JCR J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2024.08.002_bib0330","doi-asserted-by":"crossref","first-page":"e000776","DOI":"10.1136\/lupus-2022-000776","article-title":"Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives","volume":"10","author":"Toumi","year":"2023","journal-title":"Lupus Sci Med"},{"issue":"4","key":"10.1016\/j.revmed.2024.08.002_bib0335","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/humrep\/dex372","article-title":"Endometriosis induces gut microbiota alterations in mice","volume":"33","author":"Yuan","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.revmed.2024.08.002_bib0340","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.copbio.2014.09.005","article-title":"The small intestine microbiota, nutritional modulation and relevance for health","volume":"32","author":"El Aidy","year":"2015","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"10.1016\/j.revmed.2024.08.002_bib0345","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14309\/ajg.0000000000000501","article-title":"ACG clinical guideline: small intestinal bacterial overgrowth","volume":"115","author":"Pimentel","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.revmed.2024.08.002_bib0350","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3389\/fpsyt.2020.00664","article-title":"Small intestinal bacterial overgrowth and irritable bowel syndrome-an update","volume":"11","author":"Takakura","year":"2020","journal-title":"Front Psychiatry"},{"issue":"6","key":"10.1016\/j.revmed.2024.08.002_bib0355","doi-asserted-by":"crossref","first-page":"G1089","DOI":"10.1152\/ajpgi.00574.2004","article-title":"Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity","volume":"290","author":"Pimentel","year":"2006","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.revmed.2024.08.002_bib0360","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2982.2011.01819.x","article-title":"The effects of methane and hydrogen gases produced by enteric bacteria on ileal motility and colonic transit time","volume":"24","author":"Jahng","year":"2012","journal-title":"Neurogastroenterol Motil"},{"issue":"7","key":"10.1016\/j.revmed.2024.08.002_bib0365","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/apt.12456","article-title":"Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment","volume":"38","author":"Grace","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"15","key":"10.1016\/j.revmed.2024.08.002_bib0370","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.3390\/nu14153217","article-title":"Altered tryptophan metabolism on the kynurenine pathway in depressive patients with small intestinal bacterial overgrowth","volume":"14","author":"Chojnacki","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.revmed.2024.08.002_bib0375","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/1751-2980.13189","article-title":"Impact of small intestinal bacterial overgrowth on symptoms and quality of life in irritable bowel syndrome","volume":"24","author":"Chuah","year":"2023","journal-title":"J Dig Dis"},{"key":"10.1016\/j.revmed.2024.08.002_bib0380","doi-asserted-by":"crossref","first-page":"628741","DOI":"10.3389\/fimmu.2021.628741","article-title":"The gut microbiome in Myalgic Encephalomyelitis (ME)\/Chronic Fatigue Syndrome (CFS)","volume":"12","author":"K\u00f6nig","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.revmed.2024.08.002_bib0385","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/ijerph20010093","article-title":"Personality, anxiety, and stress in patients with small intestine bacterial overgrowth syndrome. The Polish Preliminary Study","volume":"20","author":"Kossewska","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.revmed.2024.08.002_bib0390","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mehy.2008.08.003","article-title":"Hypothesis: chronic fatigue syndrome is caused by dysregulation of hydrogen sulfide metabolism","volume":"72","author":"Lemle","year":"2009","journal-title":"Med Hypoth"},{"issue":"10","key":"10.1016\/j.revmed.2024.08.002_bib0395","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.3390\/ijms21103531","article-title":"The influence of small intestinal bacterial overgrowth in digestive and extra-intestinal disorders","volume":"21","author":"Losurdo","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.revmed.2024.08.002_bib0400","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1038\/s41424-018-0030-7","article-title":"Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis","volume":"9","author":"Rao","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"10.1016\/j.revmed.2024.08.002_bib0405","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1743-7075-7-79","article-title":"Gut inflammation in chronic fatigue syndrome","volume":"7","author":"Lakhan","year":"2010","journal-title":"Nutr Metab"},{"issue":"4","key":"10.1016\/j.revmed.2024.08.002_bib0410","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2020.06.090","article-title":"AGA Clinical practice update on small intestinal bacterial overgrowth: expert review","volume":"159","author":"Quigley","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.revmed.2024.08.002_bib0415","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.autrev.2015.01.018","article-title":"Fecal calprotectin in systemic sclerosis and review of the literature","volume":"14","author":"Marie","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.revmed.2024.08.002_bib0420","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000116777","article-title":"Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth","volume":"26","author":"Montalto","year":"2008","journal-title":"Dig Dis"},{"issue":"5","key":"10.1016\/j.revmed.2024.08.002_bib0425","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ajg.2017.46","article-title":"Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American Consensus","volume":"112","author":"Rezaie","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.revmed.2024.08.002_bib0430","first-page":"344","article-title":"The treatment of celiac disease with the specific carbohydrate diet; report on 191\u00a0additional cases","volume":"23","author":"Haas","year":"1955","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.revmed.2024.08.002_bib0435","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gutjnl-2020-321191","article-title":"Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis","volume":"69","author":"Black","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.revmed.2024.08.002_bib0440","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.dld.2020.10.032","article-title":"COLIGENTA treatment of small intestinal bacterial overgrowth. Results of an open study","volume":"53","author":"Bouchoucha","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.revmed.2024.08.002_bib0445","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5056\/jnm22187","article-title":"Symptomatic response to antibiotics in patients with small intestinal bacterial overgrowth: a systematic review and meta-analysis","volume":"30","author":"Takakura","year":"2024","journal-title":"J Neurogastroenterol Motil"},{"issue":"5","key":"10.1016\/j.revmed.2024.08.002_bib0450","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.revmed.2024.08.002_bib0455","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3892\/mco.2016.807","article-title":"Prevalence and treatment of small intestinal bacterial overgrowth in postoperative patients with colorectal cancer","volume":"4","author":"Deng","year":"2016","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"10.1016\/j.revmed.2024.08.002_bib0460","first-page":"2954","article-title":"Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"11\u201312","key":"10.1016\/j.revmed.2024.08.002_bib0465","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1046\/j.1365-2036.2003.01800.x","article-title":"Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease","volume":"18","author":"Castiglione","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.revmed.2024.08.002_bib0470","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2036.2005.02562.x","article-title":"Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis","volume":"22","author":"Sajjad","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.revmed.2024.08.002_bib0475","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jcf.2011.06.008","article-title":"Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth","volume":"10","author":"Lisowska","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.revmed.2024.08.002_bib0480","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MEG.0000000000000557","article-title":"A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Ghoshal","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.revmed.2024.08.002_bib0485","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0016-5085(99)70336-7","article-title":"Antibiotic efficacy in small intestinal bacterial overgrowth\u2013related chronic diarrhea: a crossover, randomized trial","volume":"117","author":"Attar","year":"1999","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.revmed.2024.08.002_bib0490","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/gut.42.2.266","article-title":"Omeprazole induces altered bile acid metabolism","volume":"42","author":"Shindo","year":"1998","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.revmed.2024.08.002_bib0495","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/MPG.0b013e3182952e93","article-title":"Effectiveness of trimethoprim-sulfamethoxazole and metronidazole in the treatment of small intestinal bacterial overgrowth in children living in a slum","volume":"57","author":"Tahan","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.revmed.2024.08.002_bib0500","first-page":"412","article-title":"Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study","volume":"98","author":"Pimentel","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.revmed.2024.08.002_bib0505","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/MCG.0b013e3181c64c90","article-title":"A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test","volume":"44","author":"Low","year":"2010","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.revmed.2024.08.002_bib0510","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10620-007-0065-1","article-title":"A systematic review of diagnostic tests for small intestinal bacterial overgrowth","volume":"53","author":"Khoshini","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.revmed.2024.08.002_bib0515","first-page":"435","article-title":"Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth","volume":"5","author":"Pimentel","year":"2009","journal-title":"Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.revmed.2024.08.002_bib0520","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1572-0241.2008.02030.x","article-title":"Small intestinal bacterial overgrowth recurrence after antibiotic therapy","volume":"103","author":"Lauritano","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.revmed.2024.08.002_bib0525","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/rheumatology\/kep226","article-title":"Small intestinal bacterial overgrowth in systemic sclerosis","volume":"48","author":"Marie","year":"2009","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.revmed.2024.08.002_bib0530","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","article-title":"Probiotics for preventing and treating small intestinal bacterial overgrowth: a meta-analysis and systematic review of current evidence","volume":"51","author":"Zhong","year":"2017","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.revmed.2024.08.002_bib0535","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10620-018-4945-3","article-title":"Effect of Bifidobacterium infantis 35624 (Align) on the lactulose breath test for small intestinal bacterial overgrowth","volume":"63","author":"Kumar","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"21","key":"10.1016\/j.revmed.2024.08.002_bib0540","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1056\/NEJM199111213252102","article-title":"Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma","volume":"325","author":"Soudah","year":"1991","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.revmed.2024.08.002_bib0545","first-page":"1251","volume":"96","author":"Madrid","year":"2001","journal-title":"Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function: Am J Gastroenterol"},{"issue":"10196","key":"10.1016\/j.revmed.2024.08.002_bib0550","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(19)31266-8","article-title":"The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications","volume":"394","author":"Allegretti","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.revmed.2024.08.002_bib0555","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12876-021-01630-x","article-title":"Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.revmed.2024.08.002_bib0560","first-page":"203","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann Gastroenterol"},{"issue":"1","key":"10.1016\/j.revmed.2024.08.002_bib0565","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12986-022-00700-5","article-title":"Antimicrobial treatment improves tryptophan metabolism and mood of patients with small intestinal bacterial overgrowth","volume":"19","author":"Chojnacki","year":"2022","journal-title":"Nutr Metab"},{"issue":"8","key":"10.1016\/j.revmed.2024.08.002_bib0570","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/rheumatology\/ken140","article-title":"Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome","volume":"47","author":"Goebel","year":"2008","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.revmed.2024.08.002_bib0575","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/ard.2003.011502","article-title":"A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing","volume":"63","author":"Pimentel","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.revmed.2024.08.002_bib0580","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.sjpain.2016.07.004","article-title":"A low fermentable oligo-di-mono saccharides and polyols(FODMAP) diet reduced pain and improve ddaily life in fibromyalgia patients","volume":"13","author":"Marum","year":"2016","journal-title":"Scand J Pain"},{"issue":"22","key":"10.1016\/j.revmed.2024.08.002_bib0585","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.3748\/wjg.v29.i22.3400","article-title":"Epidemiology of small intestinal bacterial overgrowth","volume":"29","author":"Efremova","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"21","key":"10.1016\/j.revmed.2024.08.002_bib0295","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.3390\/nu14214562","article-title":"Low-FODMAP diet for the management of irritable bowel syndrome in remission of IBD","volume":"14","author":"Wi\u0119cek","year":"2022","journal-title":"Nutrients"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324007355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324007355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T13:01:50Z","timestamp":1736427710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866324007355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0248866324007355"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2024.08.002","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SIBO, quand un mythe devient r\u00e9alit\u00e9","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2024.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}